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Abstract: Objective: To study the effect of obesity on Flow Volume curves of middle aged individuals with 
obstructive pulmonary disease. Background: Obesity and obstructive pulmonary disease quite often co-exist in 
the same individual seeking treatment for respiratory illness. Not many studies have been done about the impact 
of obesity
 on dynamic respiratory mechanics in patients with obstructive lung disease in South India. Materials 
& Methods: This is a retrospective cross sectional study where data was collected from the Department of 
Pulmonary Medicine, JSS hospital, Mysore. 120 normotensive non diabetic subjects in the age group of 40-60 
years, were divided into four groups based on their BMI and the presence of obstructive findings. Flow Volume 
loop,  FEV1,  FVC and  FEV1/ FVC  were  recorded  using  computerised  spirometer.  Results:  The  measured 
FEV1/FVC % in obese patients with obstructive findings was significantly lower than in normal BMI patients 
with  obstructive  findings.  Obese  individuals  without  obstructive  findings  also  showed  significantly  lower 
measured  FEV1/FVC  %  than  normal  BMI  individuals  without  obstructive  findings.  Conclusion: Obese 
individuals have more obstruction when compared to even normal BMI individuals with symptoms. As the 
changes in respiratory mechanics due to obesity are almost completely reversible, early intervention in obese 
patients with COPD will ensure lower dependence on medicines to manage the respiratory condition. 
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Introduction 
In order to be fit, we humans have to maintain our 
body weight within given range as per our age, 
height, gender and body type. Hence food intake 
must  be  balanced  with  the  requirement  and 
should  not  exceed  it  on  a  routine  basis.  Also, 
daily  physical  activity  is  a  must  to  expend  the 
excess  energy.  Energy  intake  should  match 
energy  expenditure  to  maintain  stable  body 
weight over the long term. Certain inbuilt body 
mechanisms exist for this purpose.  For example, 
signals  acting  on  hypothalamic  receptors 
ultimately  control  adipose  tissue  mass  through 
their  effect  on  autonomic  nervous  system  [1]. 
But,  such  mechanisms  are  overwhelmed  when 
there is chronic imbalance between energy intake 
and  expenditure  resulting  in  changes  in  the 
adipose tissue mass. 
 
Obesity is among the important health challenges 
of  the  present  century.  What  was  earlier  the 
preserve  of  the  so  called  developed  western 
nations  has  now  spread  its  tentacles  widely, 
engulfing  the  world.  Rapid  urbanization, 
increased  mechanisation  of  chores  and 
addiction to television, computer, videogames 
etc. has resulted in a very sedentary lifestyle. 
Added  to  this  are  the  rise  in  disposable 
incomes, fast paced life and easy availability 
of  unhealthy  but  tasty  junk  food.  It  is  no 
wonder then that the prevalence of obesity is 
fast  reaching  epidemic  proportions  in  India. 
Obesity  is  associated  with  numerous  co-
morbidities  such  as  cardiovascular
  diseases 
(CVD),  Hypertension,  Type  2  Diabetes  and 
sleep  apnoea.  It  is  also  an  independent
  risk 
cardiovascular disease and is associated with 
reduced  life  expectancy.  The  prevalence  of 
overweight  status  and  obesity  is  increasing 
among Indian children and adolescents which 
are reflected by various studies [2]. 
 
Many  researchers  have  demonstrated  the 
negative  physiological  effects  of  obesity  on 
lung function [3-4]. The main characteristic of 
obstructive  pulmonary  disease  is  poorly 
reversible  limitation  in  airflow  [5]. 
Physiological  variables  such  as  Forced 
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and Forced Vital Capacity (FVC) are often used 
to  grade  its  severity.  Chronic  Obstructive 
Pulmonary Disease (COPD) is characterised by a 
reduced FEV1 and a decreased ratio of FEV1 to 
FVC.  Airway  obstruction  in  COPD  is  an 
important  cause  of  exertional  breathlessness, 
slowly  progressing  to  marked  disability  and 
respiratory failure, limiting the daily activities of 
an  individual,  finally  confining  him/her  to  bed 
[6].  Globally,  COPD  has  emerged  as  a  major 
cause of morbidity and mortality. It is expected to 
become the third  leading cause of death and  the 
fifth leading cause of loss of ‘Disability Adjusted 
Life  Years’  (DALYs)  as  per  projections  of  the 
Global  Burden  of  Disease  Study  (GBDS).  The 
total  burden  of  COPD  in  India  has  more  than 
doubled  to  about  14.84  million  in  2011  from 
about 6.45 million in 1971 [6]. 
 
In recent times, obesity and obstructive features 
are often observed in the same individual seeking 
treatment for respiratory illness. There are very 
few studies done in South India about the impact 
of  obesity
 on  dynamic  respiratory  mechanics, 
dyspnoea and exercise intolerance
 in patients with 
obstructive  disease  of  the  airways  [7].  We 
hypothesised that if the effect of obesity on the 
Flow  Volume  curves  (which  assessed  the 
respiratory capacity) in patients with Obstructive 
lung disease were better understood, it would be 
of  more  help  to  the  primary  care  clinician  to 
diagnose and treat such patients. Thus, our aim 
was  to  study  the effect  of  obesity  on the  Flow 
Volume  curves  of middle aged  individuals  with 
obstructive pulmonary disease. 
 
Material and Methods 
This is a retrospective cross sectional study based 
on  the  data  recorded  in  the  Department  of 
Pulmonary  Medicine,  JSS  hospital,  Mysore 
during June-July 2011. The study group consisted 
of  patients  referred  to  the  department  for 
evaluation of their pulmonary function. The data 
of  those  120  individuals  who  fulfilled  the 
inclusion and exclusion criteria was taken up for 
the purpose of the study. 
 
Following were the inclusion criteria: 
i)  Age group 40-60 years. 
ii)  Obstructive  symptoms  (shortness  of  breath/ 
exertional  breathlessness)  of  more  than  one 
month duration. 
iii) Blood pressure and Blood glucose levels 
within normal range. 
 
The exclusion criteria were: 
i)  Patients who were known cases of COPD 
and/or taking treatment for the same. 
ii)  Patients with chronic systemic illness like 
Diabetes,  Hypertension,  Coronary  heart 
disease etc. or on regular medication for 
the same. 
iii) Those who were underweight. 
 
Their Body Mass Index (BMI) was calculated 
using Quetelet’s formula [8].  
 
BMI =     Weight (in kilograms)____  
                    Square of Height (in metres)  
 
and  they  were  classified  as  Obese  or  as 
Normal BMI [8]. 
 
Procedure:  All  the  subjects  were  initially 
familiarised  with  the  test  instrument  - 
computerised  spirometer  (Spirobank  G  - 
MIR).  The  procedure  was  explained  clearly 
and  sufficient  demonstration  given.  The 
testing was done between 10AM – 12 Noon in 
the PFT room which was well ventilated. The 
patient was comfortably seated and was asked 
to exhale air as forcefully and as rapidly as 
possible,  into  the  mouthpiece  of  the 
computerised spirometer, followed by a deep 
inspiration.  Flow  Volume  loop,  FEV1, 
FVC and  FEV1/ FVC  were  recorded.  Each 
patient did the test three times with a gap of 
minimum three minutes between two efforts. 
The best of the three readings was considered 
for analysis. 
 
Normal values  of  FVC  and  FEV1 indicated 
normal  PFT.  Low  values  indicated  the 
presence  of  respiratory  pathology 
(obstruction/ restriction).  When the measured 
value of FEV1/FVC was 50% or less than the 
predicted  value,  it  indicated  the  presence  of 
obstruction [9] as per the Global Initiative for 
Chronic  Obstructive  Lung  Disease  (GOLD) 
recommended spirometry guidelines [10].  
 
In  normal  spirometry,  both  FEV1  and  FVC 
were above 80% predicted and FEV1 / FVC 
ratio above 0.7. 
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In  obstructive  disease,  FEV1  is  below  80%  of 
predicted, FVC can be normal / reduced (usually 
to  a  lesser  degree  than  FEV1)  and  FEV1/FVC 
ratio is below 0.7. 
 
Based  on  the  above,  the  study  groups  were 
classified as follows: 
 
Group A - Normal weight patients (BMI 18- 22.9 
kg /m
2) [8] with obstructive findings. 
 
Group B - Obese patients (BMI > 25 kg/m
2) [8] 
with obstructive findings. 
Group C - Normal weight patients (BMI 18- 
22.9 kg /m
2) without obstructive findings. 
 
Group D - Obese patients (BMI > 25 kg/m
2) 
without obstructive findings. 
 
There were 30 subjects in each of the study 
groups  and  hence  a  total  of  120  subjects 
overall. Statistical analysis was done by one 
way ANOVA test using SPSS version-16 for 
Windows.  p  value  <  0.05  was  taken  as 
significant.  Post  hoc  statistical  test  applied 
was Scheffe’s analysis. 
 
Results 
Table-1: Respiratory parameters evaluated by computerised spirometry in the study subjects 
Group A 
Non-obese with 
obstruction 
Group B 
Obese with 
obstruction 
Group C 
Non-obese without 
obstruction 
Group D 
Obese without 
obstruction 
FEV1/ FVC 
(in %) 
Mean  SD  Mean  SD  Mean  SD  Mean  SD 
p-
value 
Predicted  80.95  0.80  81.36  0.56  86.96  2.98  86.87  2.65  0.00 
Measured  49.32  5.57  48.79  5.92  86.36  4.34  84.87  3.5  0.00 
% of Predicted  60.94  6.88  59.95  7.23  99.3  3.8  97.69  3.62  0.00 
 
The measured FEV1/FVC % in Group B (Obese 
with  obstruction)  was  significantly  lower  {p< 
0.05}  than  in  Group  A  (Non  -  obese  with 
obstruction). Also the measured FEV1/FVC % in 
Group  D  (Obese  without  obstruction)  was 
significantly less {p< 0.05} than in Group C (Non 
- obese without obstruction). 
 
Discussion 
Obesity is defined as abnormal or excessive fat 
accumulation  that  may  impair  health.  BMI 
correlates highly with body fat and is therefore a 
useful  measure  in  clinical  assessment  and 
epidemiological  studies  [11].  While  there  has 
been a lot of focus on the impact of obesity on 
cardiovascular and metabolic diseases, not much 
attention  has  been  paid  to  its  effects  on 
pulmonary  function  or  in  inflammation  [11].  A 
pioneering study was done by Richard Jones and 
Mary Magdalene in 2005 on the effects of BMI 
on  lung  volumes  [4].  Since  then  several 
longitudinal studies have shown that increase in 
body weight can lead to reduction in pulmonary 
function but it is unclear if obesity status alone 
represents an appropriate predictor of obstructive 
lung dysfunction. 
Spirometry  is  a  simple  method  to  assess 
respiratory  capacity  even in  a  basic  primary 
healthcare setup. Physicians interpreting lung 
function results should bear in mind obesity as 
a cause of decreased lung volumes even in the 
healthy  [12].  Using  a  rule  of  thumb,  an 
approximate 0.5% decrease in VC, TLC and 
RV can be expected with each unit increase in 
BMI in normal individuals [3].  
 
Splinting of the diaphragm by intra-abdominal 
fat  may  prevent  its  complete  descent. 
Pulmonary  compliance  is  decreased  by  the 
deposition  of  subcutaneous  adipose  tissue, 
acting  as  a  fat  envelope,  in  the  chest  wall. 
Respiratory  muscle  function  may  also  be 
compromised,  both  by  an  initial  mechanical 
disadvantage caused by fat and by the need to 
use more energy to expand the lungs than is 
used  by  a  lean  individual.  Gas  exchange 
deficit may be caused by underventilation of 
well perfused lower lung regions, which has 
been observed in obesity [12]. Contrary to the 
norm,  one  study  showed  relatively  higher 
BMI subjects with less obstructive pulmonary 
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in  populations  with  low  prevalence  of  obesity. 
Hence  high  BMI  status  alone  may  be 
inappropriate  as  a  predictor  of  obstructive  lung 
dysfunction in such cases [11]. 
 
The  GOLD  guidelines  define  COPD  as  a 
preventable  and  treatable  disease  with  some 
significant  extra-pulmonary  effects  that  may 
contribute to the severity in individual patients. 
Its  pulmonary  component  is  characterized  by 
airflow limitation that is not fully reversible. The 
airflow  limitation  is  usually  progressive  and 
associated  with  an  abnormal  inflammatory 
response of the lung to noxious particles or gases 
[13].  
 
The main clinical features of COPD are:  
•  Chronic cough, which may be continuous and 
productive, but can also be intermittent and 
unproductive. 
•  Breathlessness  on  exertion,  initially 
intermittent, later becoming persistent. 
•  Sputum  production:  any  pattern  of  sputum 
production may indicate COPD 
•  Frequent exacerbations of bronchitis. 
•  A  history  of  exposure  to  risk  factors, 
especially tobacco smoke, occupational dusts, 
home cooking and biomass fuels [13]. 
 
Although  FEV1  /  FVC  represents  the  most 
important  marker  of  lung  function  (since 
diagnosis of both COPD and asthma is based on 
FEV1/FVC),  most  articles  have  proposed 
associations  between  obese  status  and  airway 
obstruction in terms of FEV1 or FVC alone. Few 
have  argued  associations  with  FEV1/FVC  [11]. 
Despite these important concerns, the limitations 
imposed  on  respiratory  function  by  obesity  are 
recognized only occasionally and have received 
relatively little attention. We believe that obesity 
related  alterations  in  breathing  are  critical  to 
pulmonary function at rest and during exercise in 
a  large  section  of  the  population.  This  is 
especially true for patients with mild-to-moderate 
obesity who are yet to develop obesity related co-
morbidity, but depend on exercise as a means to 
combat obesity [3]. 
 
Remarkably,  a  study  has  shown  that  despite 
having  greater  metabolic  and  ventilation 
requirements,  obese  COPD  patients  do  not 
experience  greater  dyspnoea  and  exercise 
limitation  than  non-obese  patients  with 
comparable airway obstruction. This, in part, 
reflects the mechanical advantage of breathing 
at  relatively  lower  lung  volumes  in  obesity. 
But  this  finding  has  not  been  verified  in 
subsequent  studies  [7].  Despite  the  GOLD 
guidelines, there persists confusion regarding 
diagnosis of COPD especially at the level of 
primary  care  physicians.  Early  diagnosis 
remains difficult as most patients come to the 
doctor  only  when  the  obstructive  symptoms 
persist  and  worsen.  This  might  be  several 
months  to  years  after  the  initial  onset  of 
symptoms.  The  destruction  in  airways  and 
lung parenchyma, which has occurred by that 
time,  cannot  be  reversed  completely.  The 
mainly symptomatic treatment merely serves 
to  protect  the  remaining  airways  from 
pathology  and  limit  the  damage  already 
occurred. Patients find it highly frustrating as 
many do not notice any improvement in their 
symptoms  despite  being  treated  for  a  long 
time. By their refusal, either overt or covert, to 
quit smoking, many patients even worsen their 
respiratory status.  
 
According  to  our  study,  obese  individuals 
suffer  more  obstruction  in  comparison  to 
normal  BMI  individuals  in  those  with 
symptoms  of  Obstructive  lung  disease.  
Similar  finding  was  seen  even  in  those 
without any respiratory disease. This was an 
important observation because the changes in 
respiratory  mechanics  due  to  obesity  are 
almost completely reversible. Modification of 
lifestyle and changes in diet would help bring 
down  their  BMI  to  normal  range,  thereby 
improving  their  respiratory  parameters.  As 
they improve clinically, patients too are more 
compliant to treatment and more amenable to 
counseling. This is economically more viable 
in a country like ours where most patients can 
ill  afford  expensive  drugs  prescribed  for 
COPD which have very less effect clinically.  
 
Obese and overweight individuals who come 
for  treatment  of  non  respiratory  illness  may 
also be cautioned regarding obesity’s effect on 
the  respiratory  system  and  the  necessity  to 
maintain  BMI  within  normal  limits.  Hence 
early  intervention,  in  the  guise  of  lifestyle 
modifications, limited exercise and / or drugs, 
in obese patients with obstructive lung disease Al Ameen J Med Sci; Volume 6, No.4, 2013                                                                                                              Anithu C et al 
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will  ensure  lower  dependence  on  medicines  to 
manage  the  respiratory  condition,  postpone 
complications  by  delaying  progress  of  the 
pathological  process,  improve  quality  of  life  of 
the  patient  and  significantly  reduce  the  disease 
burden on the community. 
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